Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Vaporized Cannabis and Alcohol Co-Administration on Impairment
NCT06293040Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol and ethanol (7 arms), sponsored by Johns Hopkins University. Primary endpoints: DRUID application global impairment score up to 6 hours, Correct Trials on Paced Auditory Serial Addition Task up to 6 hours and 11 more. Started Sep 2024; status: recruiting.
02
Drugs
dronabinolethanol
Beyond the preview
Go deeper on NCT06293040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06293040.